DNA synthesis sites

DNA synthesis sites, often referred to as replication factories or replication forks, are specialized sub-nuclear regions where the complex machinery of DNA replication is organized and active. These sites involve the coordinated assembly of numerous proteins and enzymes, including DNA polymerases, helicases, primases, and sliding clamps like PCNA, which work together to ensure the accurate and timely duplication of the genome during the S-phase of the cell cycle [1][2]. In a therapeutic context, the process of DNA synthesis is a primary target for many antineoplastic and antimicrobial agents. These drugs typically interfere with the replication machinery by acting as antimetabolites that deplete essential nucleotide precursors or by directly inhibiting the enzymatic activity of DNA polymerases [3][4]. Because DNA synthesis is a fundamental requirement for cell division, targeting these sites is highly effective against rapidly proliferating cancer cells and infectious pathogens. However, this lack of specificity also leads to significant toxicity in healthy, fast-dividing tissues such as the bone marrow and intestinal epithelium, presenting a major clinical challenge [5]. [1] https://pmc.ncbi.nlm.nih.gov/articles/PMC3501162/ [2] https://www.nature.com/articles/nrm1839 [3] https://www.ncbi.nlm.nih.gov/books/NBK554540/ [4] https://pubchem.ncbi.nlm.nih.gov/compound/Fluorouracil [5] https://www.cancer.gov/about-cancer/treatment/types/chemotherapy

Other names

DNA replication forkReplication factoryReplisomeDNA replication machinerySites of DNA synthesis

Inhibition of DNA polymerases, depletion of deoxyribonucleotide triphosphate (dNTP) pools, or incorporation of nucleotide analogs leading to chain termination and DNA damage.